AmStem Reports Positive Early Results From SteMixxTM Consumer Study
By admin on Jul 16, 2010 in Health and Fitness
AmStem Corporation (OTCBB: AMST), a leading provider of biotherapeutic and cosmetic stem cell products, stem cell collection and storage expertise and access to nanotechnology vital to stem cell research, announced positive early results from its preliminary consumer study of SteMixx™. David Stark, President of AmStem International, Inc. said, “During the first few days, we asked participants of our initial consumer study of SteMixx™ for their initial impressions. We were not surprised but certainly pleased at how positively they responded…
Credits to:Health News from Medical News Today
